Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Radiotherapy × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Prostatic Neoplasms 23 Glioblastoma 21 Squamous Cell Carcinoma of Head and Neck 18 Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 14 Sarcoma 10 Head and Neck Neoplasms 10 Glioma 9 Brain Neoplasms 9 Rectal Neoplasms 8 Astrocytoma 8 Uterine Cervical Neoplasms 7 Neoplasms 7 Esophageal Neoplasms 6 Colorectal Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Oropharyngeal Neoplasms 4 Oligodendroglioma 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Melanoma 4 Carcinoma, Squamous Cell 4 Small Cell Lung Carcinoma 3 Sarcoma, Ewing 3 Recurrence 3 Radiation Injuries 3 Lymphoma, Follicular 3 Lymphoma 3

Interventions

Cyclophosphamide 6 fludarabine 5 Mycophenolic Acid 5 Azacitidine 5 Whole-Body Irradiation 4 Tacrolimus 4 venetoclax 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 2 Vorinostat 2 Specimen Handling 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Busulfan 2 Biopsy 2 sulforaphane 1 ruxolitinib 1 enasidenib 1 cedazuridine 1 Triamcinolone 1 TAK-243 1 Stem Cell Transplantation 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Filgrastim 1 Cyclosporins 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡